NeuroBionics

Cambridge, MA · Founded 2023 · Privately Held (backing)

Developer of a neural interface technology designed to enhance the integration of bioelectronics with the human body. NeuroBionics is based in Cambridge, MA and was founded in 2023. It was valued at $33.3 million at its seed round in Dec 2025, the last priced event on record. It has raised $9.3 million across 1 recorded round; the latest was a $4.2 million seed round in Nov 2025.

PMV mark · valuation
$33.3M
Oct 2026
Priced at
its seed round
Dec 2025
Total raised
$9.3M
Last round
Seed Round
Nov 2025

Who backs NeuroBionics?

19 investors
InvestorType
Pioneer FundVenture capital
Mana VenturesVenture capital
MedTech InnovatorOther
GaingelsVenture capital
Greentown LabsOther
SBXiVenture capital
The EngineOther
Dolby Family VenturesVenture capital
Future Ventures (San Francisco)Venture capital
MIT.nanoOther
+ 9 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

NeuroBionics investors

19 investors are on record for NeuroBionics, including Pioneer Fund, Mana Ventures, MedTech Innovator and Gaingels. By type, the record holds 9 venture capital firms. The seed round in Nov 2025 drew 7 investors.

Free account
More of NeuroBionics with a free account
  • ·The complete investor list: 19 names
  • ·Watch NeuroBionics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 19 firms already write checks for companies like NeuroBionics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View